FDA approves first oral tablet for alopecia treatment (WTOP)

June 15, 2022

The Food and Drug Administration approved Olumiant, a drug that restores hair growth and can act as a treatment for alopecia Monday.

Alopecia is an autoimmune disorder in which the immune system attacks hair follicles, resulting in hair loss on the scalp and, in some cases, the rest of the body.

This is the first systemic treatment for the disorder, which affects hundreds of thousands of people every year, said Dr. Adam Friedman, professor and chair of dermatology at The George Washington University School of Medicine and Health Sciences.

“This is extraordinary,” Friedman said. “Up until now, we’ve been using many different medications, all of which are not approved and being used off-label to manage this condition. But, we had nothing else.”

 

Read the full article on WTOP.com

Latest News

August 11, 2022
The George Washington University Medical Faculty Associates COVID-19 Vaccine Center gave its last jab against the pandemic on Aug. 5.
August 9, 2022
A USCG-licensed captain, instructor, and rigging specialist has been brought safely to land after combined efforts from the George Washington University’s Maritime Medical Access team, the U.S. Coast Guard, the U.S. Air Force, commercial shipping, and assistance from a fellow yacht.
August 2, 2022
Extreme heat puts tremendous stress on your body and can lead to dehydration, heat exhaustion, and heatstroke, among other health-related consequences.